Literature DB >> 16965726

Review of resistant hypertension.

C Venkata S Ram1.   

Abstract

Despite the prevalence of hypertension, blood pressure (BP) can be controlled with effective therapy in most patients. However, in a small percentage of the hypertensive population, BP remains refractory to therapeutic measures. In such patients who have so-called "resistant" hypertension, proper evaluation and assessment have to be undertaken to improve the BP control. There are some situations or factors that may make hypertension control difficult in some patients. Therefore, it is necessary to identify possible reasons for the loss of BP control and rectify them to achieve normotension. In addition to indicated work-up for secondary causes, aggressive treatment (nonpharmacologic and pharmacologic) of hypertension is required to prevent excessive morbidity and mortality in this special population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16965726     DOI: 10.1007/s11906-006-0085-9

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  24 in total

Review 1.  Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension.

Authors:  Krishna K Gaddam; Monique N Pratt-Ubunama; David A Calhoun
Journal:  Expert Rev Cardiovasc Ther       Date:  2006-05

2.  Effects of continuous positive airway pressure versus supplemental oxygen on 24-hour ambulatory blood pressure.

Authors:  Daniel Norman; José S Loredo; Richard A Nelesen; Sonia Ancoli-Israel; Paul J Mills; Michael G Ziegler; Joel E Dimsdale
Journal:  Hypertension       Date:  2006-04-03       Impact factor: 10.190

Review 3.  Ambulatory blood pressure monitoring. When is it warranted?

Authors:  M Thibonnier
Journal:  Postgrad Med       Date:  1992-01       Impact factor: 3.840

4.  Nonsteroidal anti-inflammatory drugs (NSAIDs) and blood pressure.

Authors:  G A Fierro-Carrion; C V Ram
Journal:  Am J Cardiol       Date:  1997-09-15       Impact factor: 2.778

5.  Dependence of arterial pressure on intravascular volume in treated hypertensive patients.

Authors:  H P Dustan; R C Tarazi; E L Bravo
Journal:  N Engl J Med       Date:  1972-04-20       Impact factor: 91.245

Review 6.  Understanding and improving patient compliance.

Authors:  S A Eraker; J P Kirscht; M H Becker
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

7.  Aldosterone and refractory hypertension: a prospective cohort study.

Authors:  Michelangelo Sartori; Lorenzo A Calò; Vania Mascagna; Anna Realdi; Luisa Macchini; Laura Ciccariello; Renzo De Toni; Francesca Cattelan; Achille C Pessina; Andrea Semplicini
Journal:  Am J Hypertens       Date:  2006-04       Impact factor: 2.689

8.  Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens.

Authors:  B C van Jaarsveld; P Krijnen; F H Derkx; J Deinum; A J Woittiez; C T Postma; M A Schalekamp
Journal:  J Hum Hypertens       Date:  2001-10       Impact factor: 3.012

9.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

10.  Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension.

Authors:  A D Mejia; B M Egan; N J Schork; A J Zweifler
Journal:  Ann Intern Med       Date:  1990-02-15       Impact factor: 25.391

View more
  2 in total

Review 1.  Resistant or refractory hypertension: are they different?

Authors:  Rodrigo Modolo; Ana Paula de Faria; Aurélio Almeida; Heitor Moreno
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

2.  "Refractory" resistant hypertension: new terminology for an old problem.

Authors:  C Venkata S Ram; Russell L Silverstein
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-12-07       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.